• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿奇霉素治疗随访:慢性前列腺炎患者沙眼衣原体的抗菌药敏性

Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.

作者信息

Smelov V, Krylova T, Smelova N, Norman L

机构信息

Department of Microbiology, St Petersburg State Medical University, St Petersburg, Russia.

出版信息

Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S79-82. doi: 10.1016/j.ijantimicag.2003.09.001.

DOI:10.1016/j.ijantimicag.2003.09.001
PMID:15037332
Abstract

The antibacterial susceptibility of Chlamydia trachomatis in 138 patients with chronic prostatitis (CP) and clinical failures after antibacterial treatment with azithromycin (AZI) were investigated. Azithromycin was not found to be top-of-the-line drug in the follow-up treatment, showing only average results in vitro. The investigation of the susceptibility of chlamydia to antibiotics in causes of chronic prostatitis is highly recommended.

摘要

对138例慢性前列腺炎(CP)患者沙眼衣原体的抗菌药敏情况以及阿奇霉素(AZI)抗菌治疗后的临床失败情况进行了调查。在后续治疗中,阿奇霉素并非一线药物,体外实验结果仅为中等。强烈建议对慢性前列腺炎病因中衣原体对抗生素的药敏情况进行调查。

相似文献

1
Azithromycin treatment follow-up: antibacterial susceptibility of Chlamydia trachomatis in patients with chronic prostatitis.阿奇霉素治疗随访:慢性前列腺炎患者沙眼衣原体的抗菌药敏性
Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S79-82. doi: 10.1016/j.ijantimicag.2003.09.001.
2
In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.氟喹诺酮类、阿奇霉素和强力霉素对从患有慢性下尿路症状的男性中培养出的沙眼衣原体的体外活性。
Eur Urol. 2004 Nov;46(5):647-50. doi: 10.1016/j.eururo.2004.06.020.
3
Single-drug or combined antibacterial therapy in the treatment of patients with chronic prostatitis and Chlamydia trachomatis?单药或联合抗菌疗法治疗慢性前列腺炎合并沙眼衣原体感染患者?
Int J Antimicrob Agents. 2004 Mar;23 Suppl 1:S83-7. doi: 10.1016/j.ijantimicag.2003.09.008.
4
Eradication of Chlamydia trachomatis parallels symptom regression in chronic bacterial prostatitis patients treated with a fluoroquinolone-macrolide combination.氟喹诺酮-大环内酯类联合治疗慢性细菌性前列腺炎患者,可消除沙眼衣原体并行症状消退。
Andrologia. 2010 Dec;42(6):366-75. doi: 10.1111/j.1439-0272.2009.01033.x.
5
Comparative randomized pilot study of azithromycin and doxycycline efficacy in the treatment of prostate infection caused by Chlamydia trachomatis.阿奇霉素与多西环素治疗沙眼衣原体所致前列腺感染疗效的比较随机试点研究
Int J Antimicrob Agents. 2004 Aug;24(2):188-91. doi: 10.1016/j.ijantimicag.2004.03.014.
6
Azithromycin in the treatment of chronic prostatitis caused by Chlamydia trachomatis.阿奇霉素治疗沙眼衣原体所致慢性前列腺炎
J Chemother. 2001 Dec;13(6):664-5. doi: 10.1179/joc.2001.13.6.664.
7
Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure.多重耐药沙眼衣原体与临床治疗失败相关。
J Infect Dis. 2000 Apr;181(4):1421-7. doi: 10.1086/315372. Epub 2000 Apr 13.
8
The significance of Chlamydia trachomatis in urethritis and prostatitis - differences in therapeutic approach - Croatian experience.沙眼衣原体在尿道炎和前列腺炎中的意义——治疗方法的差异——克罗地亚的经验
J Chemother. 2009 Feb;21(1):63-7. doi: 10.1179/joc.2009.21.1.63.
9
Comparative analysis of azithromycin and clarithromycin efficacy and tolerability in the treatment of chronic prostatitis caused by Chlamydia trachomatis.阿奇霉素与克拉霉素治疗沙眼衣原体所致慢性前列腺炎的疗效及耐受性对比分析
J Chemother. 2002 Aug;14(4):384-9. doi: 10.1179/joc.2002.14.4.384.
10
[Polymerase chain reaction in the detection of patients infected by Chlamydia trachomatis after treatment].[聚合酶链反应在沙眼衣原体感染患者治疗后检测中的应用]
Zhonghua Yi Xue Za Zhi. 1997 Feb;77(2):91-3.

引用本文的文献

1
Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.嗜软骨沃氏菌在卡氏棘阿米巴中对抗生素的敏感性
Antimicrob Agents Chemother. 2009 Jun;53(6):2663-6. doi: 10.1128/AAC.00046-09. Epub 2009 Mar 30.